Surgical Sutures Market Size, Industry Trends, Demands and Forecast 2023 to 2027

Surgical sutures, commonly known as stitches, are vital medical tools used to close wounds and incisions during surgical procedures or after injuries, facilitating the natural healing process. These sutures are crafted from a variety of materials, including natural sources like catgut or silk and synthetic materials such as nylon, polypropylene, and polyester. Sutures can be categorized into absorbable ones that gradually break down within the body and non-absorbable sutures that may require removal post-healing. Sutures can also be further classified as monofilament, with a single smooth strand, or multifilament, composed of multiple strands twisted together, offering different benefits and considerations. The choice of suture material and type is based on factors like wound location, patient health, and expected healing time.

Expanding Options in Surgical Sutures: Meeting Growing Demand

The global surgical sutures market is propelled by a combination of significant factors. An increasing incidence of lifestyle-related diseases and planned surgical interventions is fueling the demand for surgical sutures. The presence of favorable reimbursement policies for a variety of surgical procedures is encouraging healthcare providers to utilize sutures more frequently. The introduction of advanced suture technologies is another key driver, as these innovations enhance the effectiveness of wound closure and healing. The growing trend for minimally invasive procedures, which require specialized sutures is also contributing to the market's growth. For instance,

• In June 2021, Ethicon announced that the National Institute for Health and Care Excellence (NICE) had updated its medical technologies guidance (MTG) to recommend the inclusion of Plus Sutures in surgical procedures conducted within the National Health Service (NHS). These sutures, coated with triclosan to prevent bacterial colonization, have gained official approval for use in the NHS, to prevent surgical site infections in the NHS, especially in cases where absorbable sutures are a suitable choice for wound closure
• In September 2020, Smith+Nephew introduced the NOVOSTITCH PRO Meniscal Repair System in Europe after obtaining the CE mark certification. This system offers significant versatility and presents a novel approach for surgeons to address meniscal tears, providing an essential tool that enables them to repair such tears with better efficiency

The rising aging population also has a significant impact on the surgical sutures market. There has been a constant rise in the number of surgical procedures due to the global population's growth and aging demographics, including elective and minimally invasive surgeries. As people age, they may require more medical procedures, including surgeries. Older individuals often have a higher prevalence of chronic health conditions that may require surgical treatments. These conditions can include joint replacements, heart surgeries, and various cancer-related surgeries. Surgical sutures are commonly used to close incisions and wounds after surgical procedures. With a larger aging population, there is a potentially increased demand for surgical interventions, which in turn is likely to drive the growth of the surgical sutures market. Improvements in surgical techniques and technology have made many surgical procedures more accessible and safer for older patients, contributing to the growing demand for surgical sutures. Collectively, these factors are shaping the landscape of the global surgical sutures market, offering both healthcare providers and patients a broader range of choices and improved outcomes.

Fill out the "Quick Inquiry Form" to request a sample copy

Evolving Suture Technologies in Modern Healthcare

Several trends are shaping the surgical suture market. The increasing popularity of minimally invasive surgeries has reduced the demand for traditional sutures while boosting the need for specialized sutures tailored to these techniques. Advancements in surgical sutures have driven the market in recent years. These developments have improved the effectiveness, safety, and versatility of sutures used in various medical procedures. Biodegradable and absorbable sutures are gaining favor as they break down naturally within the body, eliminating the need for removal and enhancing patient comfort. Innovations in wound care products, including sutures, focus on infection prevention, faster healing, and improved cosmetic outcomes are aligning with patient expectations. Surgeons are increasingly opting for synthetic sutures, such as polypropylene and polydioxanone as alternatives to traditional natural materials. Sutures with coatings, such as antimicrobial or anti-inflammatory, reduce infection risk. Advanced delivery devices enhance precision and efficiency in suturing. As minimally invasive surgery becomes more common, sutures designed for use in smaller incisions or endoscopic procedures have witnessed increased demand. For instance,

• In September 2020, Smith+Nephew introduced the HEALICOIL KNOTLESS Suture Anchor, an addition to its Advanced Healing Solutions for rotator cuff repair. This portfolio also includes the innovative REGENETEN™ Bioinductive Implant and the innovative REGENESORB™ Material. The HEALICOIL KNOTLESS Suture Anchor, with its distinctive open architecture design, in combination with REGENESORB Material, is intended to expedite bone healing and formation, providing a unique approach to the healing process

Continuous research and collaboration foster ongoing innovation in surgical sutures, promising a future of even more advanced sutures and techniques. Market consolidation through mergers and acquisitions is prevalent, allowing larger companies to expand their product portfolios and market presence. Sustainability and eco-friendliness are becoming priorities, with a focus on reducing the environmental impact through eco-friendly materials and packaging. Additionally, the growth of telemedicine and remote monitoring is influencing healthcare delivery and the choice of sutures for various procedures. These advancements have not only improved patient outcomes and recovery times but have also contributed to the overall growth of the surgical sutures market.

Key Constraints/Challenges

The global surgical suture market faces several challenges and constraints. These include the emergence of alternative wound closure methods like surgical staples and tissue adhesives, which intensify competition and limit the growth of traditional sutures. Stringent regulatory requirements pose barriers for new suture products seeking entry into the market, as achieving compliance with various standards and approvals can be both time-consuming and costly.

North America Accounts for the Largest Share of the Global Market

The North American region has asserted its dominance in the global surgical suture market. Several factors contribute to this, including a high volume of surgical procedures, demand for advanced surgical sutures, the presence of key industry players, favorable reimbursement policies, government healthcare programs, and well-developed healthcare infrastructure. 

In contrast, the Asia Pacific region is poised to experience the most rapid growth in the forecast period. Factors contributing to this growth include a growing elderly population, which often requires surgical interventions, and. growing demand for non-invasive surgical procedures, and the adoption of advanced suturing techniques.

Competitive Landscape

Some prominent players competing in the global surgical suture market include Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, Sutures India Pvt. Ltd., among others

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, and acquisitions to garner market share. For instance,

• In February 2021, GTCR, through its management partnership with Gregory T. Lucier's Corza Health, completed the acquisition and merger of Surgical Specialties Corporation and the TachoSil® Fibrin Sealant Patch. This merger has given rise to a new entity known as Corza Medical. Corza Medical will offer healthcare professionals a comprehensive platform of surgical technologies, featuring renowned brands such as QuillTM barbed sutures, LookTM surgical sutures, and other surgical products establishing a significant presence in the healthcare industry
• In December 2020, Zimmer Biomet Holdings, Inc. successfully finalized the acquisition of A&E Medical Corporation, a Vance Street Capital Portfolio Company. This acquisition includes A&E Medical's extensive range of sternal closure devices, encompassing sternal sutures, cable systems, rigid fixation, as well as various single-use temporary pacing wire and surgical punch products that complement their existing portfolio.

The market is expected to grow due to a rising aging population, growing demand for non-invasive surgical procedures, advanced surgical sutures, and aggressive organic and inorganic growth strategies followed by the players.

Surgical Sutures Market Scope